Frølund L, Madsen F, Svendsen U G, Nielsen N H, Weeke B
Clin Allergy. 1987 May;17(3):217-28. doi: 10.1111/j.1365-2222.1987.tb02006.x.
Standardized bronchial allergen provocation was performed twice in nineteen extrinsic, well defined, stable asthmatic patients, with an interval of median 15 days (range 14-19) to study the reproducibility of the bronchial response. Smoking and medications were withheld prior to the provocation after a rigid scheme. Ten-fold increasing concentrations of allergen solution 0.9 ml were inhaled by tidal volume breathing for 5 min with intervals of 10 min. The bronchial response to inhaled allergen was determined by forced expiratory volume in the first sec (FEV1) and by total resistance to breathing (Rt) determined by an opening interrupter method. The provocation was continued until an allergen concentration causing at least 20%, decrease of the postsaline FEV1 or a 40% increase in Rt was reached. A PC20-FEV1 and a PC40-Rt was calculated by interpolation on the log-dose-response curve. The reproducibility of PC20-FEV1 allergen was high with a 95% confidence interval (CI) for a single determination being the observed value +/- 0.83, ten-fold concentration difference, the intraclass correlation (IC) was 0.99 and the coefficient of variation 8.46%. Concerning PC40-Rt a 95% CI for a single determination was calculated being the observed value +/- 0.58, ten-fold concentration difference, IC was 0.99 and the coefficient of variation was 5.79%. No significant correlation was found between differences in pre-challenge FEV1 and Rt values and the corresponding PC20-FEV1 and PC40-Rt values. Least square regression between PC20-FEV1 and PC40-Rt was performed for the first and the second provocation (P less than 0.05). We conclude that bronchial allergen challenge performed in stable asthmatics is highly reproducible and as such a valuable test in the diagnosis of allergic asthma when connected with anamnesis, skin-prick test and the level of specific immunoglobulin E in peripheral blood.
对19名明确诊断为外源性、病情稳定的哮喘患者进行了两次标准化支气管过敏原激发试验,两次试验间隔时间中位数为15天(范围14 - 19天),以研究支气管反应的可重复性。在严格遵循方案的情况下,激发试验前禁止吸烟并停用药物。以潮气量呼吸方式吸入0.9毫升浓度呈10倍递增的过敏原溶液,每次吸入5分钟,间隔10分钟。通过第1秒用力呼气量(FEV1)以及采用开放式阻断器法测定的总呼吸阻力(Rt)来确定支气管对吸入过敏原的反应。激发试验持续进行,直至达到使盐水激发后FEV1至少降低20%或Rt增加40%的过敏原浓度。通过在对数剂量 - 反应曲线上进行插值计算得出PC20 - FEV1和PC40 - Rt。PC20 - FEV1过敏原的可重复性很高,单次测定的95%置信区间(CI)为观察值±0.83(10倍浓度差异),组内相关系数(IC)为0.99,变异系数为8.46%。关于PC40 - Rt,单次测定的95%CI计算为观察值±0.58(10倍浓度差异),IC为0.99,变异系数为5.79%。在激发前FEV1和Rt值的差异与相应的PC20 - FEV1和PC40 - Rt值之间未发现显著相关性。对第一次和第二次激发试验进行了PC20 - FEV1与PC40 - Rt之间的最小二乘回归分析(P < 0.05)。我们得出结论,在稳定型哮喘患者中进行的支气管过敏原激发试验具有高度可重复性,因此在结合病史、皮肤点刺试验和外周血特异性免疫球蛋白E水平进行过敏性哮喘诊断时是一项有价值的检测方法。